-
公开(公告)号:US20050142061A1
公开(公告)日:2005-06-30
申请号:US10508682
申请日:2003-03-20
申请人: Alan Cuthbertson , Magne Solbakken , Joseph Arukwe , Hege Karlsen
发明人: Alan Cuthbertson , Magne Solbakken , Joseph Arukwe , Hege Karlsen
CPC分类号: C07B59/008
摘要: The present invention relates to methods and reagents for [18F]-fluorination, particularly of peptides. The resultant 18F-labelled compounds are useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET). Thus, a compound of formula 18F-(Linker)-SH, such as a compound of formula (IV), (V), or (VI): 18F—(CH2CH2O)n—(CH2)m—SH (IV) 18F—(CH2)p—SH (V) may be reacted with an activated peptide as a means for 18F-labelling.
摘要翻译: 本发明涉及[F 18 F] - 氟化,特别是肽的方法和试剂。 所得的18 F标记的化合物可用作放射性药物,特别用于正电子发射断层扫描(PET)。 因此,通式(IV)的化合物,如式(IV),(V)或(VI)的化合物: “在线公式”end =“lead”?> 18 SUP> F-(CH 2 2 CH 2 O) β-H(IV)<βin-line-formula description =“In-line Formulas”end =“tail”?> < ?in-line-formula description =“In-line Formulas”end =“lead”?> 18 SUP> F-(CH 2) SUB> -SH(V)<βin-line-formula description =“In-line Formulas”end =“tail”?>可与活化肽反应,作为标记的标记。
-
公开(公告)号:US08231858B2
公开(公告)日:2012-07-31
申请号:US10544945
申请日:2004-02-10
申请人: Anthony Storey , Julie Davis , Sally-Ann Ricketts , Marivi Mendizabal , Alan Cuthbertson , Joseph Arukwe , Kirsty Heywood , Ian Wilson , Duncan Wynn , Michael Schafers , Bodo Levkau , Stefan Wagner , Hans-Jörg Breyholz , Klaus Kopka
发明人: Anthony Storey , Julie Davis , Sally-Ann Ricketts , Marivi Mendizabal , Alan Cuthbertson , Joseph Arukwe , Kirsty Heywood , Ian Wilson , Duncan Wynn , Michael Schafers , Bodo Levkau , Stefan Wagner , Hans-Jörg Breyholz , Klaus Kopka
CPC分类号: A61K51/0497
摘要: The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.
摘要翻译: 本发明涉及诊断成像领域。 具体地,本发明涉及已知涉及特定基质金属蛋白酶的疾病的诊断成像。 本发明的一个实施方案是具有适用于诊断成像的基质金属蛋白酶抑制活性的化合物。 本发明还公开了一种药物组合物,其包含适合哺乳动物给药形式的本发明的诊断显像剂。 本发明还公开了合成本发明的诊断显像剂的中间体和用于制备本发明的药物组合物的试剂盒。 本发明的药物组合物可用于诊断已知涉及特定基质金属蛋白酶的疾病。
-
公开(公告)号:US5962626A
公开(公告)日:1999-10-05
申请号:US977630
申请日:1997-11-25
申请人: Per Strande , Harald Dugstad , Balin Balinov , Jan Alfheim , Joseph Arukwe
发明人: Per Strande , Harald Dugstad , Balin Balinov , Jan Alfheim , Joseph Arukwe
IPC分类号: A61K8/39 , A61K8/86 , A61K47/14 , A61Q19/00 , B01F17/00 , B01F17/34 , C07C69/96 , C08G65/332 , C08G63/48 , C11D9/00
CPC分类号: C08G65/3322 , A61K47/14 , A61K8/39 , A61K8/86 , A61Q19/00 , B01F17/0028 , C07C69/96
摘要: The present invention provides a polyethylene glycol (PEG) ester surfactant comprising at least one polyethylene glycol moiety and at least one fatty acyl moiety characterized in that said moieties are linked by a linkage incorporating a biodegradable methylene diester unit of formula (I)--CO.O.C(R.sup.1)(R.sup.2).O.CO-- (I)where R.sup.1 and R.sup.2 may, for example, each be a hydrogen atom or a monovalent organic group attached through a carbon atom or R.sup.1 and R.sup.2 together may, for example, form a divalent organic group attached through carbon atoms.
摘要翻译: 本发明提供了包含至少一个聚乙二醇部分和至少一个脂肪酰基部分的聚乙二醇(PEG)酯表面活性剂,其特征在于所述部分通过结合有式(I)-CO的可生物降解的亚甲基二酯单元的连接物连接。 其中R 1和R 2可以各自为氢原子或通过碳原子连接的一价有机基团,或者R 1和R 2一起可以例如形成OC(R 1)(R 2) 通过碳原子连接的二价有机基团。
-
公开(公告)号:US20070071670A1
公开(公告)日:2007-03-29
申请号:US10544945
申请日:2004-02-10
申请人: Anthony Storey , Julie Davis , Sally-Ann Ricketts , Marivi Medizabal , Alan Cuthbertson , Joseph Arukwe , Kirsty Heywood , Ian Wilson , Duncan Wynn , Michael Schafers , Bodu Levkau , Stefan Wagner , Hans-Jorg Breyholz , Klaus Kopka
发明人: Anthony Storey , Julie Davis , Sally-Ann Ricketts , Marivi Medizabal , Alan Cuthbertson , Joseph Arukwe , Kirsty Heywood , Ian Wilson , Duncan Wynn , Michael Schafers , Bodu Levkau , Stefan Wagner , Hans-Jorg Breyholz , Klaus Kopka
IPC分类号: A61K51/00 , C07D401/02
CPC分类号: A61K51/0497
摘要: The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.
摘要翻译: 本发明涉及诊断成像领域。 具体地,本发明涉及已知涉及特定基质金属蛋白酶的疾病的诊断成像。 本发明的一个实施方案是具有适用于诊断成像的基质金属蛋白酶抑制活性的化合物。 本发明还公开了一种药物组合物,其包含适合哺乳动物给药形式的本发明的诊断显像剂。 本发明还公开了合成本发明的诊断显像剂的中间体和用于制备本发明的药物组合物的试剂盒。 本发明的药物组合物可用于诊断已知涉及特定基质金属蛋白酶的疾病。
-
-
-